RIPK3 as a potential therapeutic target for Gaucher's disease. (2014)

First Author: Vitner EB
Attributed to:  Gene Therapy for Tay-Sachs and Sandhoff diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/nm.3449

PubMed Identifier: 24441827

Publication URI: http://europepmc.org/abstract/MED/24441827

Type: Journal Article/Review

Volume: 20

Parent Publication: Nature medicine

Issue: 2

ISSN: 1078-8956